The position
You will be instrumental in the identification and segmentation of Key Opinion Leaders (KOLs) and develop engagement plans, including obtaining expert advice to guide local decisions and strategy. You will also be responsible for

• Drafting and adapting a global publication plan about the local needs and regulations and Liaise with relevant professional associations, including congress activities in support of Novo Nordisk's presence and providing guidance and training internally to support capability building in affiliate as well as giving support to clinical operations in the execution of clinical trials, in areas where medical resources to support studies are not available are also key responsibilities. Seek opportunities and advice to obtain an understanding of the market and patient pathways in support of internal medical and commercial business decisions and scientific development of therapy area and drive advanced scientific therapeutic area development. Drive launch preparation and execute launch in collaboration with cross-functional group and map healthcare system and patient care/treatment pathways and provide medical and scientific consultation/support for in/external stakeholders and support local treatment guideline.
• Excellence in scientific meetings and advisory board meetings and develop scientific agendas and contents, effective speaker engagement and KOL management, utilization of gathered insights. Ensure timely, accurate and balanced communication of data to the scientific and medical community and plan and execute abstracts, posters and oral presentations at national conferences and manuscripts regarding responsible products in journals. Be responsive and proactively alert to issues related to competitor activities and facilitate effective and timely corrective actions and secure real-world evidence (RWE) and support Investigator Sponsored Studies (ISS) for responsible products. Analyse country-level data needs to prepare for successful launches. Identify data gaps based on affiliate stakeholder needs (patients, HCPs, healthcare system, professional associations, etc), market understanding and the patient journey and develop solutions that address the stakeholder evidence needs and build the product value proposition in the disease area.
• KOL Engagement : Lead the process of KOL mapping, segmentation and engagement planning and support and enable partnership with the right KOL, on the right activity, in support of NovoNordisk's therapeutic strategies to ultimately improve patient outcomes and design KOL engagement activities to enrich relationship with Key Opinion Leaders. Plan and implement innovative ways to gather clinical insights/needs/feedback from KOLs/customers and communicate with internal stakeholders. Develop relationships with KOLs and proactively work with cross-functional group to develop product advocacy or advisory board forum discussion and engage with local associations and organizations.
• Medical Education : Increase awareness of NovoNordisk products/disease area through presentations and trainings, CMEs, according to business strategy and plan and execute non-promotional scientific activities in accordance with the company program including but not limited to medical education program, symposium, speaker training, key scientific leader program. Stay up-to-date on scientific knowledge by actively participating in scientific meetings, conferences, CMEs and sharing publications.
• Ethics & Compliance : Compliance with NovoNordisk principles and internal legal laws and to defend company interests. Nevertheless as a requirement of the business ethics; to defend the confidentiality of company as well as the patients’ privacy, business plans, ideas and strategies against third parties. Act in line with ethical standards, company procedures, and NovoNordisk Way of Management wich includes vision, policies and charter which describes our values, commitments and fundamentals. Ensure that the profile of the NN remains high amongst stakeholders like doctors, patients, paramedics, associations etc. by developing and maintaining a close rapport through liaison and networking.

• M.D with medical experience in the field.
• Ph.D. or Pharmacist or scientist/researchers with solid professional medical expertise more than 5 years in pharmaceutical industry, preferably in related disease area
• More than 5 years of Medical Affairs related experience and solid understanding of the role and activities of medical affairs in pharmaceutical industry. Experience with relevant therapy areas will be an added advantage (e.g. endocrinology, cardiovascular, etc).
• Excellent medical communication skills and understanding of different therapy areas and phases of the product lifecycle.
• Fluent in both written and spoken English.